Kenya's Pharmacy and Poisons Board warns against counterfeit Herceptin batch C5830083, initiates legal actions, and enhances market surveillance.

Kenya's Pharmacy and Poisons Board (PPB) has warned against using, selling, or distributing a counterfeit batch of cancer drug Herceptin (Trastuzumab 440mg), identified with batch number C5830083. The board has initiated legal actions against individuals involved and established robust market surveillance systems to ensure medical product quality and safety. The genuine Herceptin is manufactured by Roche Products Limited in Germany.